Integer Holdings Corporation (ITGR)

Market Cap	3.95B
Revenue (ttm)	1.60B
Net Income (ttm)	90.65M
Shares Out	33.50M
EPS (ttm)	2.69
PE Ratio	43.83
Forward PE	21.84
Dividend	n/a
Ex-Dividend Date	n/a

Volume	244,425
Open	117.30
Previous Close	116.65
Day's Range	116.65 - 118.57
52-Week Range	69.40 - 121.53
Beta	1.12
Analysts	Buy
Price Target	115.17 (-2.32%)
Earnings Date	Apr 25, 2024

About ITGR

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures. It also provides cardiac rhythm management products, including im...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Sep 29, 2000
• Employees: 10,500
• Stock Exchange: NYSE
• Ticker Symbol: ITGR

Financial Performance

In 2023, ITGR's revenue was $1.60 billion, an increase of 16.03% compared to the previous year's $1.38 billion. Earnings were $90.65 million, an increase of 36.57%.

Analyst Forecast

According to 7 analysts, the average rating for ITGR stock is "Buy." The 12-month stock price forecast is $115.17, which is a decrease of -2.32% from the latest price.

Price Target

$115.17

(-2.32% downside)

Analyst Consensus: Buy